Humanigen
Utility Patents

Last updated:

List of all Humanigen patents 4 in total

Status Patent
Grant
Utility: Method of reducing tumor relapse rate in immunotherapy by administration of lenzilumab External link
Filling date: 6 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: Immunoglobulin variable region cassette exchange External link
Filling date: 6 Sep 2025 Issue date: 16 Feb 2021
Grant
Utility: Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy-related toxicity External link
Filling date: 6 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: Methods of treating immunotherapy-related toxicity using a GM-CSF antagonist External link
Filling date: 6 Sep 2025 Issue date: 22 Dec 2020

Showing 1 to 4 of 4 patents.